Physician profile
James A Solomon
NPI 1023128345
$14,292.82
in general payments reported to CMS, 2019-2025
27 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,362 · 2020: $2,518 · 2021: $4,448 · 2022: $429 · 2023: $134 · 2024: $277 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma As | $4,334.00 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $4,213.86 | 2019-2023 | Ilumya |
| Pfizer INC. | $3,540.24 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $352.96 | 2021-2024 | Sotyktu |
| Abbvie INC. | $240.72 | 2019-2023 | Rinvoq |
| Genentech USA, INC. | $235.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $231.45 | 2019-2022 | |
| Incyte Corporation | $209.14 | 2021-2022 | |
| Genzyme Corporation | $173.81 | 2021-2025 | |
| Ucb, INC. | $145.85 | 2021-2024 | Bimzelx |
| Dermavant Sciences, INC. | $140.22 | 2024 | Vtama |
| Allergan, INC. | $123.49 | 2019 | |
| Celgene Corporation | $62.16 | 2019 | |
| Amgen INC. | $59.32 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $59.31 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $33.74 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $30.11 | 2022 | |
| Strata Skin Sciences, INC. | $22.85 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $21.42 | 2019 | |
| Lilly USA, LLC | $18.34 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.17 | 2021 | |
| Janssen Biotech, INC. | $13.82 | 2021 | |
| Mylan Pharmaceuticals INC. | $12.27 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.